Affiliation:
1. Moscow Regional Research Institute of Obstetrics and Gynecology
Abstract
The review presents modern data of the effect of hormonal contraceptives and hormone replacement therapy drugs on the risk of thromboembolic complications. The effect of components of the drugs and their dosages on the hemostasis system is presented, the use of hormonal therapy in women with extragenital diseases is discussed, the ways of reducing the thrombogenic risk of hormones with their mandatory use are debated.
Publisher
Medical Informational Agency Publishers